QIAGEN announces new collaboration to develop companion diagnostic to guide treatment for patients with PIK3CA-mutated advanced breast cancer

World News: . []

QIAGEN NV NYSE QGEN Frankfurt Prime Standard: QIA today announced that a clinical development program is underway with Novartis to bring to market a molecular test as a companion diagnostic to guide the use of the i nvestig...

More news and information about Qiagen

Published By:

Business Wire: 16:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "qiagen" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us